GRM2 and Akinesia: These data are somewhat consistent with previous data in which systemic administration of the dual mGluR2/3 agonist LY379268 weakly ameliorated reserpine-induced akinesia, but did not reverse amphetamine rotational asymmetry in 6-OHDA lesioned rats, despite modest neuroprotective effects [18].